Meyka Pro banner
MaxLinear, Inc.

MaxLinear, Inc. Fundamental Analysis (NASDAQ: MXL)

MXL●NASDAQ
TechnologySemiconductors
$59.95
$6.12(11.37%)
U.S. Market opens in 1h 23m

MaxLinear, Inc. Fundamental Analysis (NASDAQ: MXL)

MaxLinear, Inc. (NASDAQ: MXL) shows moderate financial fundamentals with a PE ratio of -171.45, profit margin of -4.45%, and ROE of -6.11%. The company generates $0.7B in annual revenue with strong year-over-year growth of 29.71%.

Key Strengths

PEG Ratio-1.02
Current Ratio2.22

Areas of Concern

ROE-6.11%
Operating Margin-0.85%
Cash Position1.49%
We analyze MXL's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 36.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
36.7/100

We analyze MXL's fundamental strength across five key dimensions:

Efficiency Score

Weak

MXL struggles to generate sufficient returns from assets.

ROA > 10%
-3.21%

Valuation Score

Excellent

MXL trades at attractive valuation levels.

PE < 25
-171.45
PEG Ratio < 2
-1.02

Growth Score

Excellent

MXL delivers strong and consistent growth momentum.

Revenue Growth > 5%
29.71%
EPS Growth > 10%
46.08%

Financial Health Score

Excellent

MXL maintains a strong and stable balance sheet.

Debt/Equity < 1
0.35
Current Ratio > 1
2.22

Profitability Score

Weak

MXL struggles to sustain strong margins.

ROE > 15%
-610.67%
Net Margin ≥ 15%
-4.45%
Positive Free Cash Flow
No

Key Financial Metrics

Is MXL Expensive or Cheap?

P/E Ratio

MXL trades at -171.45 times earnings. This suggests potential undervaluation.

-171.45

PEG Ratio

When adjusting for growth, MXL's PEG of -1.02 indicates potential undervaluation.

-1.02

Price to Book

The market values MaxLinear, Inc. at 10.22 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

10.22

EV/EBITDA

Enterprise value stands at 161.00 times EBITDA. This signals the market has high growth expectations.

161.00

How Well Does MXL Make Money?

Net Profit Margin

For every $100 in sales, MaxLinear, Inc. keeps $-4.45 as profit after all expenses.

-4.45%

Operating Margin

Core operations generate -0.85 in profit for every $100 in revenue, before interest and taxes.

-0.85%

ROE

Management delivers $-6.11 in profit for every $100 of shareholder equity.

-6.11%

ROA

MaxLinear, Inc. generates $-3.21 in profit for every $100 in assets, demonstrating efficient asset deployment.

-3.21%

Following the Money - Real Cash Generation

Operating Cash Flow

MaxLinear, Inc. generates limited operating cash flow of $-7.24M, signaling weaker underlying cash strength.

$-7.24M

Free Cash Flow

MaxLinear, Inc. generates weak or negative free cash flow of $-20.59M, restricting financial flexibility.

$-20.59M

FCF Per Share

Each share generates $-0.23 in free cash annually.

$-0.23

FCF Yield

MXL converts -0.38% of its market value into free cash.

-0.38%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-171.45

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-1.02

vs 25 benchmark

P/B Ratio

Price to book value ratio

10.22

vs 25 benchmark

P/S Ratio

Price to sales ratio

8.24

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.35

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.22

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.06

vs 25 benchmark

ROA

Return on assets percentage

-0.03

vs 25 benchmark

ROCE

Return on capital employed

-0.01

vs 25 benchmark

How MXL Stacks Against Its Sector Peers

MetricMXL ValueSector AveragePerformance
P/E Ratio-171.4532.70 Better (Cheaper)
ROE-6.11%758.00% Weak
Net Margin-4.45%-4312.00% (disorted) Weak
Debt/Equity0.350.96 Strong (Low Leverage)
Current Ratio2.2212.15 Strong Liquidity
ROA-3.21%1067467.00% Weak

MXL outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews MaxLinear, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-17.47%

Industry Style: Growth, Innovation, High Beta

Declining

EPS CAGR

-17.09%

Industry Style: Growth, Innovation, High Beta

Declining

FCF CAGR

-77.48%

Industry Style: Growth, Innovation, High Beta

Declining

Fundamental Analysis FAQ